Related Experiment Video

Updated: Jan 23, 2026

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

1.4K

MiR-193a-3p inhibits pancreatic ductal adenocarcinoma cell proliferation by targeting CCND1

Zhi-Min Chen1, Qiao Yu1, Gang Chen1

  • 1Department of Pathology, First Affiliated Hospital of Guangxi Medical University, Nanning, People's Republic of China.

Cancer Management and Research
|June 20, 2019
PubMed

Insights

MicroRNA-193a-3p targets CCND1 to inhibit pancreatic ductal adenocarcinoma (PDAC) growth. This microRNA may serve as a tumor suppressor, offering a potential therapeutic strategy for PDAC.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • MicroRNAs (miRNAs) regulate gene expression posttranscriptionally, influencing cancer development.
  • Dysregulation of miRNAs is implicated in various oncogenic processes.

Purpose of the Study:

  • To investigate the role of miR-193a-3p in pancreatic ductal adenocarcinoma (PDAC).
  • To elucidate the regulatory relationship between miR-193a-3p and its target gene CCND1 in PDAC.

Main Methods:

  • Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) for gene expression analysis.
  • Cell proliferation, apoptosis, and cell cycle assays (CCK-8, flow cytometry).
  • Bioinformatic analysis and dual-luciferase reporter assays to confirm target gene interaction.

Main Results:

  • miR-193a-3p expression was significantly reduced in PDAC tissues compared to non-cancerous tissues.
  • Overexpression of miR-193a-3p inhibited PDAC cell proliferation, induced apoptosis, and caused cell cycle arrest.
  • CCND1 was identified as a direct target of miR-193a-3p, with its expression downregulated upon miR-193a-3p upregulation.

Conclusions:

  • miR-193a-3p suppresses tumor growth in PDAC by targeting CCND1.
  • miR-193a-3p acts as a tumor inhibitor in PDAC, suggesting its potential as a therapeutic and prognostic marker.
Keywords:
CCND1PDACmiR-193a-3pproliferation

More Related Videos

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma06:21

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

Published on: November 19, 2019

12.1K
Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line06:24

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Published on: April 11, 2025

882

Related Concept Videos

Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
56.9K
Cells Coordinate Growth and Proliferation02:36

Cells Coordinate Growth and Proliferation

Cell size is a significant factor impacting cellular design, function, and fitness. There exists some internal coordination by which cells double their masses before division, thus, achieving homeostasis. Coordination between cell growth and proliferation depends on the checkpoints in between cell cycle phases. Loss of coordination or failure in the checkpoint mechanism can drive the cell to uncontrolled growth and loss of cellular function. Like dividing cells that coordinate cellular growth,...
5.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
91.7K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.8K
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
5.3K